These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7733682)

  • 21. [Prognostic factors of infiltrating tumors of the bladder].
    Maulard-Durdux C; Housset M
    Cancer Radiother; 1998 Apr; 2 Suppl 1():5s-11s. PubMed ID: 9749069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular biology of brain tumors.
    Wu JK; Naber SP
    Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The concept of oncogenes and anti-oncogenes].
    Jeanteur P; Pujol H; Theillet C
    Pathol Biol (Paris); 1992 Nov; 39(9):857. PubMed ID: 1538907
    [No Abstract]   [Full Text] [Related]  

  • 25. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
    Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
    Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-oncogenes and cancer].
    May P
    Pathol Biol (Paris); 1992 Nov; 39(9):864. PubMed ID: 1538911
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
    Hornigold N; Devlin J; Davies AM; Aveyard JS; Habuchi T; Knowles MA
    Oncogene; 1999 Apr; 18(16):2657-61. PubMed ID: 10353610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder].
    Baud E; Catilina P; Bignon YJ
    Bull Cancer; 1997 Oct; 84(10):971-5. PubMed ID: 9435799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The correlation between integration of HBV X, S, Pre-S, C gene and the expression of oncogenes/tumor suppressor genes in primary hepatocellular carcinoma].
    Zhang L; Cao Y; Song J
    Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):138-9. PubMed ID: 10572677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation patterns in non-ras oncogenes and tumour suppressor genes in experimentally induced tumours.
    Perantoni AO; Rice JM
    IARC Sci Publ; 1999; (146):87-122. PubMed ID: 10353385
    [No Abstract]   [Full Text] [Related]  

  • 31. The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology.
    Petty RD
    Clin Oncol (R Coll Radiol); 1996; 8(3):186-9. PubMed ID: 8814375
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cancer--a disease of the genes].
    Sauter G
    Praxis (Bern 1994); 1998 Apr; 87(16):535-7. PubMed ID: 9600016
    [No Abstract]   [Full Text] [Related]  

  • 33. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
    Takle LA; Knowles MA
    Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenesis, genetic instability and genomic entropy: insight derived from malignant brain tumor age specific mortality rate dynamics.
    Riggs JE
    J Theor Biol; 1994 Oct; 170(4):331-8. PubMed ID: 7996860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly differentiated transitional cell carcinoma versus leiomyosarcoma of the ureter: different defects in tumour suppressor genes.
    Tzen CY; Wu CJ; Huang ZD; Wu TY
    Histopathology; 2007 Aug; 51(2):271-3. PubMed ID: 17593211
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.